<?xml version="1.0" encoding="UTF-8"?>
<p>It appears that research during the pandemic is taking place at an unprecedented pace, with both journal editors and research scientists who donate time in the peer reviewing process being overwhelmed with new information, trying to understand the pathophysiology of the coronavirus, or to elucidate effective treatments and vaccines. And it is during this time, when the academic system has stretched its capacity thin, that political motivation seizes the opportunity to step in. Indeed, the politicization of the pandemic is suspected to have played a role in the article published in The Lancet, if only to rebuke the US President, Mr Donald Trump, who vigorously endorsed hydroxychloroquine as both preventive and curative treatment for COVID-19 (
 <xref rid="b34-mmr-22-04-3035" ref-type="bibr">34</xref>). This study resulted in the WHO and other health organizations halting clinical trials before substantial reviews could be conducted on the safety of these anti-malarial drugs, with immediate repercussions for many thousand patients worldwide.
</p>
